NCT02085603View on ClinicalTrials.gov

SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 21, 2018

Study Completion Date

January 21, 2018

Conditions
Cancer
Interventions
DRUG

Saracatinib

DRUG

Placebo

Trial Locations (1)

S10 1SN

Sheffield Teaching Hospitals NHS Trust, Sheffield

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER